Alnara Bags $35 Million B Round, to Seek Approval for Cystic Fibrosis Drug

Alnara Pharmaceuticals … says it has nabbed $35 million in a Series B funding round as it puts the finishing touches on the paperwork it needs to complete before asking the FDA for permission to sell its first product, an enzyme-replacement drug for patients with cystic fibrosis.
Xconomy